Latka logo
Allocate Software logo

Allocate Software

United States

Valuation

$2.8M

2023 Revenue

$947.5K

Funding

$0

Team

12

How Allocate Software grew to $947.5K revenue with a 12 person team in 2023.

AllocateSoftware is a leading provider of innovative software solutions designed to streamline resource allocation and optimize operational efficiency for businesses of all sizes.

Last updated

Allocate Software Revenue

In 2023, Allocate Software's revenue reached $947.5K. Since its launch, Allocate Software has shown consistent revenue growth.

Allocate Software Revenue GrowthReported revenue / ARR over time$0$200K$400K$600K$800K$1M2023$947.5KSource: GetLatka.com
YearMilestoneQuote
2023Allocate Software Hit $947.5k revenue in December 2023

Allocate Software Valuation, Funding Rounds

Allocate Software's most recent disclosed valuation is $2.8M.

No funding has been reported for Allocate Software yet.

Founder / CEO

We don't have Allocate Software's Founder / CEO on record yet.

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for Allocate Software yet.

Allocate Software Employees & Team Size

Allocate Software employs approximately 12 people as of 2026, down from 14 in 2022.

Allocate Software Team GrowthReported headcount over time036912152022202314141212Source: GetLatka.com
YearMilestone
2023Reached 12 employees (December 2023)
2022Reached 14 employees (December 2022)

Frequently Asked Questions about Allocate Software

What is Allocate Software's revenue?

Allocate Software generates $947.5K in revenue.

How much funding does Allocate Software have?

Allocate Software raised $0.

How many employees does Allocate Software have?

Allocate Software has 12 employees.

Where is Allocate Software headquarters?

Allocate Software is headquartered in United States.

Compare Allocate Software to the industry

Allocate Software operates across multiple industries. Browse revenue, funding, and growth data for Allocate Software in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile

People Also Viewed

SpringRock Ventures logo

SpringRock Ventures

Founded in 2015, SpringRock Ventures is a venture capital firm that invests nationwide and is based in Seattle, Washington. The firm focuses on the convergence of technology and healthcare. Key investment sectors include SAAS, digital health, tech-enabled services, fintech, devices, oral health, eCommerce of healthcare, IT, security/HIPAA.

Sqillzer logo

Sqillzer

Isn't it odd that everything in the online world is being measured except the people who work in it?

SuperSaaS logo

SuperSaaS

SuperSaaS provides a web service to create a flexible web based scheduling system that you can add to your own web site.The system can be used as a simple shared calendar or as a fully fledged booking system which gives it a wide range of application. It is in use by universities, fitness centres, individuals, churches, and many others.The company intends to expand their service offering to other web services over the coming years.SuperSaaS was named one of the 10 best application user interfaces of 2008 by web guru Jakob Nielsen.

Sinngular logo

Sinngular

BeWell Digital logo

BeWell Digital

Building the operating system for diagnosis.

iSEEit Inc. logo

iSEEit Inc.

The iSEEit Opportunity Management Tool is the first native Salesforce app that lets you easily manage MEDDIC (and other sales methodologies)for all your opportunities and visualize your sales process on Salesforce. Lack of proper qualification is the #1 cause of slipped deals. iSEEit gives you a common language and a visual approach – so you know exactly what to focus on. No more "hopecasting". iSEEit’s visual forecast lets you see exactly what’s been accomplished and what’s missing, so you know where submitted deals actually stand.